SCHEMBL7859686

SCHEMBL7859686

COC(=O)Nc1nc2ccc(-c3ccc4c(c3)CN(c3ncnc5cc(OC)c(OC)cc35)CCO4)cc2[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 2/20 0.44
PDGFRB P09619 11/20 0.42
PDGFRA P16234 5/20 0.42
GAK O14976 1/20 0.42
ACHE P22303 2/20 0.41
BACE1 P56817 2/20 0.41
AURKA O14965 1/20 0.41
LMNA P02545 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
BLM P54132 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KIT P10721 3/20 0.40
FLT3 P36888 3/20 0.40
KDR P35968 1/20 0.40
PIK3CA P42336 1/20 0.40
TUBB4A P04350 1/20 0.40
TUBB P07437 1/20 0.40
TUBA3C P0DPH7 1/20 0.40
TUBA1B P68363 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3714926 0.94 PDGFRB (0.44) PDE10APDGFRBPDGFRAGAKACHE
SCHEMBL13056673 0.91 MTNR1B (0.44) PDGFRBAURKALMNAPOLBHPGD
SCHEMBL7858604 0.90 LMNA (0.47) AURKALMNAPOLBHPGDBLM
SCHEMBL7865632 0.89 NCF1 (0.41) PDGFRBLMNAPOLBHPGDBLM
SCHEMBL861756 0.89 PDE10A (0.44) PDE10APDGFRBPDGFRAGAKACHE
SCHEMBL13056671 0.88 LMNA (0.41) AURKALMNAPOLBHPGDBLM
SCHEMBL857984 0.87 PDE10A (0.48) PDE10APDGFRBPDGFRAGAKACHE
SCHEMBL856679 0.85 PDE10A (0.42) PDE10APDGFRBPDGFRAGAKACHE
SCHEMBL3716243 0.85 MTNR1B (0.44) PDGFRBAURKALMNAPOLBPIK3CA
SCHEMBL13056676 0.84 CREBBP (0.47) AURKALMNAPOLBHPGDBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PDE10A 758/4885PDGFRB 1294/4885PDGFRA 1516/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA PDE10A 663/4885PDGFRB 1410/4885PDGFRA 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.